139 related articles for article (PubMed ID: 1361132)
1. Dose selection for toxicity studies: a protocol for determining the maximum repeatable dose.
Spurling NW; Carey PF
Hum Exp Toxicol; 1992 Nov; 11(6):449-57. PubMed ID: 1361132
[TBL] [Abstract][Full Text] [Related]
2. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
Buckley LA; Dorato MA
Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
[TBL] [Abstract][Full Text] [Related]
3. Reasons for monitoring kinetics in safety evaluation studies.
Hawkins DR; Chasseaud LF
Arch Toxicol Suppl; 1985; 8():165-72. PubMed ID: 3868346
[TBL] [Abstract][Full Text] [Related]
4. Considerations in the design of toxicokinetic programs.
Cayen MN
Toxicol Pathol; 1995; 23(2):148-57. PubMed ID: 7569669
[TBL] [Abstract][Full Text] [Related]
5. Exploratory EEG studies for the assessment of neurological liabilities in conscious dogs in early drug development.
Breidenbach L; Potschka H; Hempel K
J Pharmacol Toxicol Methods; 2019; 98():106581. PubMed ID: 31102738
[TBL] [Abstract][Full Text] [Related]
6. Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies.
Dahlem AM; Allerheiligen SR; Vodicnik MJ
Toxicol Pathol; 1995; 23(2):170-8. PubMed ID: 7569672
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
8. A model-based assay design to reproduce in vivo patterns of acute drug-induced toxicity.
Kuepfer L; Clayton O; Thiel C; Cordes H; Nudischer R; Blank LM; Baier V; Heymans S; Caiment F; Roth A; Fluri DA; Kelm JM; Castell J; Selevsek N; Schlapbach R; Keun H; Hynes J; Sarkans U; Gmuender H; Herwig R; Niederer S; Schuchhardt J; Segall M; Kleinjans J
Arch Toxicol; 2018 Jan; 92(1):553-555. PubMed ID: 28852801
[No Abstract] [Full Text] [Related]
9. Use of toxicokinetics to support chemical evaluation: Informing high dose selection and study interpretation.
Creton S; Saghir SA; Bartels MJ; Billington R; Bus JS; Davies W; Dent MP; Hawksworth GM; Parry S; Travis KZ
Regul Toxicol Pharmacol; 2012 Mar; 62(2):241-7. PubMed ID: 22198561
[TBL] [Abstract][Full Text] [Related]
10. An international appraisal of the minimum duration of chronic animal toxicity studies.
Lumley CE; Parkinson C; Walker SR
Hum Exp Toxicol; 1992 May; 11(3):155-62. PubMed ID: 1352109
[TBL] [Abstract][Full Text] [Related]
11. Issues related to the use of canines in toxicologic pathology--issues with pharmacokinetics and metabolism.
Tibbitts J
Toxicol Pathol; 2003; 31 Suppl():17-24. PubMed ID: 12597427
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Benzyl Alcohol (CAS No. 100-51-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Jun; 343():1-158. PubMed ID: 12724782
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
14. Toxicokinetics/toxicodynamic correlations: goals, methods, and limitations.
Batra VK
Toxicol Pathol; 1995; 23(2):158-64. PubMed ID: 7569670
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of US Food and Drug Administration and pharmacologically guided approaches to determine the maximum recommended starting dose for first-in-human clinical trials in adult healthy men.
Imam MT; Venkateshan SP; Tandon M; Saha N; Pillai KK
J Clin Pharmacol; 2011 Dec; 51(12):1655-64. PubMed ID: 21415286
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (1-Chloro-2-Methylpropene) (CAS No. 513-37-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1986 Aug; 316():1-238. PubMed ID: 12748737
[TBL] [Abstract][Full Text] [Related]
17. Single dose toxicity and repeated dose toxicity studies: introductory remarks.
Kurokawa Y; Matsuzawa T
J Toxicol Sci; 1996 Dec; 21(5):413-6. PubMed ID: 9035047
[No Abstract] [Full Text] [Related]
18. Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range.
Sandhu P; Vogel JS; Rose MJ; Ubick EA; Brunner JE; Wallace MA; Adelsberger JK; Baker MP; Henderson PT; Pearson PG; Baillie TA
Drug Metab Dispos; 2004 Nov; 32(11):1254-9. PubMed ID: 15286054
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic and metabolic studies in the development of drugs].
Vereczkey L
Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
